Regent Peak Wealth Advisors LLC Sells 437 Shares of The Procter & Gamble Company (NYSE:PG)

Regent Peak Wealth Advisors LLC lowered its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 3.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,924 shares of the company’s stock after selling 437 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in Procter & Gamble were worth $1,892,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. Wulff Hansen & CO. grew its stake in shares of Procter & Gamble by 16,292.0% in the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after acquiring an additional 3,653,477 shares in the last quarter. TD Asset Management Inc increased its stake in shares of Procter & Gamble by 114.9% in the first quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after buying an additional 1,907,716 shares during the period. AMF Tjanstepension AB raised its position in Procter & Gamble by 416.1% during the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock worth $315,016,000 after purchasing an additional 1,466,115 shares during the last quarter. Swedbank AB acquired a new stake in shares of Procter & Gamble in the first quarter valued at about $233,788,000. Finally, Ilex Capital Partners UK LLP acquired a new stake in Procter & Gamble during the 1st quarter valued at approximately $228,212,000. Institutional investors and hedge funds own 65.77% of the company’s stock.

Insider Buying and Selling

In related news, CEO Jon R. Moeller sold 7,007 shares of the firm’s stock in a transaction on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the completion of the sale, the chief executive officer now owns 269,172 shares of the company’s stock, valued at $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other news, CFO Andre Schulten sold 13,041 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now directly owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction dated Wednesday, October 2nd. The shares were sold at an average price of $171.65, for a total transaction of $1,202,751.55. Following the sale, the chief executive officer now directly owns 269,172 shares in the company, valued at $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 383,194 shares of company stock valued at $65,140,718 over the last ninety days. 0.17% of the stock is owned by insiders.

Procter & Gamble Price Performance

NYSE PG traded down $1.29 on Wednesday, reaching $172.28. 2,567,059 shares of the company’s stock traded hands, compared to its average volume of 6,664,147. The stock has a market cap of $406.60 billion, a PE ratio of 28.03, a P/E/G ratio of 3.67 and a beta of 0.41. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The Procter & Gamble Company has a 12 month low of $142.50 and a 12 month high of $177.94. The stock has a 50-day simple moving average of $171.68 and a 200 day simple moving average of $166.96.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share for the quarter, topping the consensus estimate of $1.37 by $0.03. The business had revenue of $20.53 billion during the quarter, compared to the consensus estimate of $20.69 billion. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The firm’s revenue for the quarter was down .1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.37 earnings per share. As a group, research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 annualized dividend and a yield of 2.34%. Procter & Gamble’s payout ratio is currently 65.69%.

Wall Street Analyst Weigh In

PG has been the subject of several research reports. Royal Bank of Canada lifted their price target on shares of Procter & Gamble from $157.00 to $164.00 and gave the company a “sector perform” rating in a research report on Wednesday, July 31st. Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Wolfe Research upgraded Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. BNP Paribas assumed coverage on Procter & Gamble in a research note on Monday, June 24th. They set an “outperform” rating and a $187.00 price objective on the stock. Finally, Evercore ISI boosted their price objective on Procter & Gamble from $177.00 to $183.00 and gave the stock an “outperform” rating in a research report on Thursday, July 18th. Nine investment analysts have rated the stock with a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $176.21.

Get Our Latest Report on Procter & Gamble

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

Recommended Stories

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.